speb/financial-data huggingface dataset:
CLGN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -61000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 110000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 104000.00
CLGN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -11000.00
CLGN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2878000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Common Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9305000.00
CLGN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLGN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 269000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1226000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Current Assets: 9622000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 788000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 788000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2632000.00
CLGN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 223000.00
CLGN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 223000.00
CLGN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 12722203.00
CLGN income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.27
CLGN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — EBIT: -3507000.00
CLGN income_statement (quarterly, 2025-09-30) — EBITDA: -3284000.00
CLGN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -9000.00
CLGN cash_flow (quarterly, 2025-09-30) — End Cash Position: 8547000.00
CLGN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
CLGN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2878000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 88000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4245000.00
CLGN income_statement (quarterly, 2025-09-30) — Gross Profit: -192000.00
CLGN income_statement (quarterly, 2025-09-30) — Interest Income: 24000.00
CLGN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 24000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Inventory: 540000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9305000.00
CLGN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1000.00
CLGN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLGN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2152000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2152000.00
CLGN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3483000.00
CLGN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3483000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Interest Income: 24000.00
CLGN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 24000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Net PPE: 4245000.00
CLGN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 9217000.00
CLGN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3284000.00
CLGN income_statement (quarterly, 2025-09-30) — Normalized Income: -3483000.00
CLGN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2877000.00
CLGN income_statement (quarterly, 2025-09-30) — Operating Income: -3507000.00
CLGN income_statement (quarterly, 2025-09-30) — Operating Revenue: 77000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12776385.00
CLGN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -969000.00
CLGN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -74000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 134000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Other Properties: 4245000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 243000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Payables: 618000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1844000.00
CLGN income_statement (quarterly, 2025-09-30) — Pretax Income: -3483000.00
CLGN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CLGN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Receivables: 254000.00
CLGN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 269000.00
CLGN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 223000.00
CLGN income_statement (quarterly, 2025-09-30) — Research And Development: 2089000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 281000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -121632000.00
CLGN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
CLGN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1226000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Share Issued: 12794794.00
CLGN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 282000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9305000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 9217000.00
CLGN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Assets: 14089000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9305000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Debt: 2940000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9305000.00
CLGN income_statement (quarterly, 2025-09-30) — Total Expenses: 3584000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4784000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4467000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2152000.00
CLGN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3507000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2025-09-30) — Working Capital: 6990000.00
CLGN income_statement (annual, 2025-12-31) — +Operating Expense: 13019000.00
CLGN income_statement (quarterly, 2025-12-31) — +Operating Expense: 3018000.00
CLGN income_statement (annual, 2025-12-31) — +Total Revenue: 2371000.00
CLGN income_statement (quarterly, 2025-12-31) — +Total Revenue: 60000.00
CLGN balance_sheet (annual, 2025-12-31) — Accounts Payable: 610000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 610000.00
CLGN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1000.00
CLGN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7878000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7878000.00
CLGN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 126397000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 126397000.00
CLGN income_statement (annual, 2025-12-31) — Basic Average Shares: 12203269.00
CLGN income_statement (annual, 2025-12-31) — Basic EPS: -0.94
CLGN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 11909000.00
CLGN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8547000.00
CLGN cash_flow (annual, 2025-12-31) — Capital Expenditure: -28000.00
CLGN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -15000.00
CLGN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2846000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2846000.00
CLGN balance_sheet (annual, 2025-12-31) — Capital Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5492000.00
CLGN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5591000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5591000.00
CLGN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5591000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5591000.00
CLGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3102000.00
CLGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CLGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -27000.00
CLGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15000.00
CLGN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9419000.00
CLGN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2935000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Account Payable: -260000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -8000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -46000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 22000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Inventory: -129000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Inventory: -32000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 666000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 170000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -336000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -94000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Payable: -260000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Payable: -8000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -306000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 14000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Receivables: 359000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 30000.00
CLGN cash_flow (annual, 2025-12-31) — Change In Working Capital: 254000.00
CLGN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 88000.00
CLGN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 149000.00
CLGN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 10000.00
CLGN cash_flow (annual, 2025-12-31) — Changes In Cash: -6344000.00
CLGN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2950000.00
CLGN balance_sheet (annual, 2025-12-31) — Common Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Common Stock: 5492000.00
CLGN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6081000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6081000.00
CLGN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3102000.00
CLGN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLGN income_statement (annual, 2025-12-31) — Cost Of Revenue: 835000.00
CLGN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 192000.00
CLGN balance_sheet (annual, 2025-12-31) — Current Assets: 6747000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Current Assets: 6747000.00
CLGN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 814000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 814000.00
CLGN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 814000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 814000.00
CLGN balance_sheet (annual, 2025-12-31) — Current Liabilities: 2672000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2672000.00
CLGN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 912000.00
CLGN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 216000.00
CLGN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 912000.00
CLGN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 216000.00
CLGN income_statement (annual, 2025-12-31) — Diluted Average Shares: 12203269.00
CLGN income_statement (annual, 2025-12-31) — Diluted EPS: -0.94
CLGN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3207000.00
CLGN income_statement (annual, 2025-12-31) — EBIT: -11483000.00
CLGN income_statement (quarterly, 2025-12-31) — EBIT: -3150000.00
CLGN income_statement (annual, 2025-12-31) — EBITDA: -10571000.00
CLGN income_statement (quarterly, 2025-12-31) — EBITDA: -2934000.00
CLGN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 26000.00
CLGN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -6000.00
CLGN cash_flow (annual, 2025-12-31) — End Cash Position: 5591000.00
CLGN cash_flow (quarterly, 2025-12-31) — End Cash Position: 5591000.00
CLGN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3102000.00
CLGN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
CLGN balance_sheet (annual, 2025-12-31) — Finished Goods: 290000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 290000.00
CLGN cash_flow (annual, 2025-12-31) — Free Cash Flow: -9447000.00
CLGN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2950000.00
CLGN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CLGN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -371000.00
CLGN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 73000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 73000.00
CLGN balance_sheet (annual, 2025-12-31) — Gross PPE: 11767000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 11767000.00
CLGN income_statement (annual, 2025-12-31) — Gross Profit: 1536000.00
CLGN income_statement (quarterly, 2025-12-31) — Gross Profit: -132000.00
CLGN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 16000.00
CLGN income_statement (annual, 2025-12-31) — Interest Income: 380000.00
CLGN income_statement (quarterly, 2025-12-31) — Interest Income: 329000.00
CLGN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 380000.00
CLGN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 329000.00
CLGN balance_sheet (annual, 2025-12-31) — Inventory: 573000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Inventory: 573000.00
CLGN balance_sheet (annual, 2025-12-31) — Invested Capital: 6081000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6081000.00
CLGN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -27000.00
CLGN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -15000.00
CLGN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3102000.00
CLGN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CLGN balance_sheet (annual, 2025-12-31) — Leases: 3660000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Leases: 3660000.00
CLGN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2032000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2032000.00
CLGN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2032000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2032000.00
CLGN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 875000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 875000.00
CLGN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3102000.00
CLGN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CLGN cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -80000.00
CLGN income_statement (annual, 2025-12-31) — Net Income: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3207000.00
CLGN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -11489000.00
CLGN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3207000.00
CLGN income_statement (annual, 2025-12-31) — Net Interest Income: 365000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Interest Income: 314000.00
CLGN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 365000.00
CLGN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 314000.00
CLGN balance_sheet (annual, 2025-12-31) — Net PPE: 3889000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Net PPE: 3889000.00
CLGN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -27000.00
CLGN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -15000.00
CLGN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6008000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6008000.00
CLGN income_statement (annual, 2025-12-31) — Normalized EBITDA: -10200000.00
CLGN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2934000.00
CLGN income_statement (annual, 2025-12-31) — Normalized Income: -11118000.00
CLGN income_statement (quarterly, 2025-12-31) — Normalized Income: -3207000.00
CLGN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -9419000.00
CLGN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2935000.00
CLGN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -80000.00
CLGN income_statement (annual, 2025-12-31) — Operating Income: -11483000.00
CLGN income_statement (quarterly, 2025-12-31) — Operating Income: -3150000.00
CLGN income_statement (annual, 2025-12-31) — Operating Revenue: 2371000.00
CLGN income_statement (quarterly, 2025-12-31) — Operating Revenue: 60000.00
CLGN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12803006.00
CLGN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12803006.00
CLGN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -969000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -969000.00
CLGN income_statement (annual, 2025-12-31) — Other Income Expense: -371000.00
CLGN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -15000.00
CLGN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 66000.00
CLGN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 76000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 76000.00
CLGN balance_sheet (annual, 2025-12-31) — Other Payable: 62000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Other Payable: 62000.00
CLGN balance_sheet (annual, 2025-12-31) — Other Properties: 7232000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Other Properties: 7232000.00
CLGN balance_sheet (annual, 2025-12-31) — Other Receivables: 223000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Other Receivables: 223000.00
CLGN balance_sheet (annual, 2025-12-31) — Payables: 672000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Payables: 672000.00
CLGN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 672000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 672000.00
CLGN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1186000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1186000.00
CLGN income_statement (annual, 2025-12-31) — Pretax Income: -11489000.00
CLGN income_statement (quarterly, 2025-12-31) — Pretax Income: -3207000.00
CLGN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CLGN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CLGN balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLGN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLGN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -28000.00
CLGN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -15000.00
CLGN balance_sheet (annual, 2025-12-31) — Receivables: 224000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Receivables: 224000.00
CLGN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 835000.00
CLGN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 192000.00
CLGN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 912000.00
CLGN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 216000.00
CLGN income_statement (annual, 2025-12-31) — Research And Development: 8187000.00
CLGN income_statement (quarterly, 2025-12-31) — Research And Development: 1980000.00
CLGN balance_sheet (annual, 2025-12-31) — Restricted Cash: 359000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 359000.00
CLGN balance_sheet (annual, 2025-12-31) — Retained Earnings: -124839000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -124839000.00
CLGN cash_flow (annual, 2025-12-31) — Sale Of PPE: 1000.00
CLGN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CLGN income_statement (annual, 2025-12-31) — Selling General And Administration: 4832000.00
CLGN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1038000.00
CLGN balance_sheet (annual, 2025-12-31) — Share Issued: 12821415.00
CLGN balance_sheet (quarterly, 2025-12-31) — Share Issued: 12821415.00
CLGN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 999000.00
CLGN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -18000.00
CLGN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6081000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6081000.00
CLGN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6008000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6008000.00
CLGN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CLGN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (annual, 2025-12-31) — Total Assets: 10785000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Assets: 10785000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Capitalization: 6081000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6081000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Debt: 2846000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Debt: 2846000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6081000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6081000.00
CLGN income_statement (annual, 2025-12-31) — Total Expenses: 13854000.00
CLGN income_statement (quarterly, 2025-12-31) — Total Expenses: 3210000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4704000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4704000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4038000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4038000.00
CLGN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2032000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2032000.00
CLGN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -11483000.00
CLGN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -3150000.00
CLGN income_statement (annual, 2025-12-31) — Total Other Finance Cost: 15000.00
CLGN income_statement (annual, 2025-12-31) — Total Unusual Items: -371000.00
CLGN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -371000.00
CLGN balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (annual, 2025-12-31) — Work In Process: 283000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Work In Process: 283000.00
CLGN balance_sheet (annual, 2025-12-31) — Working Capital: 4075000.00
CLGN balance_sheet (quarterly, 2025-12-31) — Working Capital: 4075000.00
CLGN income_statement (quarterly, 2026-03-31) — +Operating Expense: 2872000.00
CLGN income_statement (quarterly, 2026-03-31) — +Total Revenue: 73000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 635000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 8000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 127526000.00
CLGN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 13747204.00
CLGN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.23
CLGN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5591000.00
CLGN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2649000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6265000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4262000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4262000.00
CLGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1719000.00
CLGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -6000.00
CLGN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3049000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 25000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -235000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -103000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 177000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -183000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Payable: 25000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -210000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Receivables: -9000.00
CLGN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -328000.00
CLGN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -7000.00
CLGN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1336000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Common Stock: 6265000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4886000.00
CLGN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 316000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1013000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Current Assets: 5539000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 794000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 794000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2442000.00
CLGN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 210000.00
CLGN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 210000.00
CLGN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 13747204.00
CLGN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.23
CLGN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — EBIT: -3115000.00
CLGN income_statement (quarterly, 2026-03-31) — EBITDA: -2905000.00
CLGN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 7000.00
CLGN cash_flow (quarterly, 2026-03-31) — End Cash Position: 4262000.00
CLGN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1719000.00
CLGN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3055000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 59000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3508000.00
CLGN income_statement (quarterly, 2026-03-31) — Gross Profit: -243000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Inventory: 679000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4886000.00
CLGN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -6000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1855000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1855000.00
CLGN cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -10000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3097000.00
CLGN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3097000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Interest Income: 18000.00
CLGN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 18000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Net PPE: 3508000.00
CLGN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4827000.00
CLGN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2905000.00
CLGN income_statement (quarterly, 2026-03-31) — Normalized Income: -3097000.00
CLGN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -3049000.00
CLGN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -10000.00
CLGN income_statement (quarterly, 2026-03-31) — Operating Income: -3115000.00
CLGN income_statement (quarterly, 2026-03-31) — Operating Revenue: 73000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 14423253.00
CLGN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -969000.00
CLGN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -4000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 77000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Other Properties: 3508000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Other Receivables: 225000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Payables: 635000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1648000.00
CLGN income_statement (quarterly, 2026-03-31) — Pretax Income: -3097000.00
CLGN cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 1719000.00
CLGN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -6000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Receivables: 233000.00
CLGN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 316000.00
CLGN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 210000.00
CLGN income_statement (quarterly, 2026-03-31) — Research And Development: 1678000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 365000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -127936000.00
CLGN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CLGN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1194000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Share Issued: 14441662.00
CLGN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 180000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4886000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4827000.00
CLGN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Assets: 9183000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4886000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Debt: 2649000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4886000.00
CLGN income_statement (quarterly, 2026-03-31) — Total Expenses: 3188000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4297000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3644000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1855000.00
CLGN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3115000.00
CLGN income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -18000.00
CLGN balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2026-03-31) — Working Capital: 3097000.00
CLH income_statement (annual, 2021-12-31) — Amortization: 34748000.00
CLH cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 34700000.00
CLH cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 34700000.00
CLH balance_sheet (annual, 2021-12-31) — Cash Equivalents: 0.00
CLH balance_sheet (annual, 2021-12-31) — Cash Financial: 452575000.00
CLH cash_flow (annual, 2021-12-31) — Change In Working Capital: 12298000.00
CLH cash_flow (annual, 2021-12-31) — Depreciation: 263400000.00
CLH cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -219700000.00
CLH cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CLH balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 17383000.00
CLH balance_sheet (annual, 2021-12-31) — Prepaid Assets: 68483000.00
CLH cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CLH cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CLH income_statement (annual, 2022-12-31) — +Operating Expense: 987928000.00
CLH income_statement (annual, 2022-12-31) — +Total Revenue: 5166605000.00
CLH balance_sheet (annual, 2022-12-31) — Accounts Payable: 446629000.00
CLH balance_sheet (annual, 2022-12-31) — Accounts Receivable: 964603000.00
CLH balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2486127000.00
CLH balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 504240000.00
CLH balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -45253000.00
CLH income_statement (annual, 2022-12-31) — Amortization: 50237000.00
CLH cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 50200000.00
CLH cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 50200000.00
CLH income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 50237000.00
CLH income_statement (annual, 2022-12-31) — Basic Average Shares: 54223000.00
CLH income_statement (annual, 2022-12-31) — Basic EPS: 7.59
CLH cash_flow (annual, 2022-12-31) — Beginning Cash Position: 452575000.00
CLH balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 591397000.00
CLH cash_flow (annual, 2022-12-31) — Capital Expenditure: -347022000.00
CLH balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 168791000.00
CLH balance_sheet (annual, 2022-12-31) — Capital Stock: 541000.00
CLH balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 492603000.00
CLH balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 554636000.00
CLH balance_sheet (annual, 2022-12-31) — Cash Equivalents: 34008000.00
CLH balance_sheet (annual, 2022-12-31) — Cash Financial: 458595000.00
CLH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -187315000.00
CLH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -388944000.00
CLH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 626214000.00
CLH cash_flow (annual, 2022-12-31) — Change In Account Payable: 74460000.00
CLH cash_flow (annual, 2022-12-31) — Change In Inventory: -74547000.00
CLH cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -17303000.00
CLH cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 30521000.00
CLH cash_flow (annual, 2022-12-31) — Change In Payable: 74460000.00
CLH cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 74460000.00
CLH cash_flow (annual, 2022-12-31) — Change In Receivables: -201087000.00
CLH cash_flow (annual, 2022-12-31) — Change In Working Capital: -187956000.00
CLH cash_flow (annual, 2022-12-31) — Changes In Cash: 49955000.00
CLH balance_sheet (annual, 2022-12-31) — Common Stock: 541000.00
CLH balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1922322000.00
CLH cash_flow (annual, 2022-12-31) — Common Stock Payments: -50183000.00
CLH balance_sheet (annual, 2022-12-31) — Construction In Progress: 140328000.00
CLH income_statement (annual, 2022-12-31) — Cost Of Revenue: 3543930000.00
CLH balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 212048000.00
CLH balance_sheet (annual, 2022-12-31) — Current Assets: 2033761000.00
CLH balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 49532000.00
CLH balance_sheet (annual, 2022-12-31) — Current Debt: 10000000.00
CLH balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 59532000.00
CLH balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 94094000.00
CLH balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 94094000.00
CLH balance_sheet (annual, 2022-12-31) — Current Liabilities: 1020094000.00
CLH balance_sheet (annual, 2022-12-31) — Current Provisions: 23123000.00
CLH cash_flow (annual, 2022-12-31) — Deferred Income Tax: 17549000.00
CLH cash_flow (annual, 2022-12-31) — Deferred Tax: 17549000.00
CLH cash_flow (annual, 2022-12-31) — Depreciation: 297400000.00
CLH cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 347594000.00
CLH income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 347594000.00
CLH cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 347594000.00
CLH income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 347594000.00
CLH income_statement (annual, 2022-12-31) — Depreciation Income Statement: 297357000.00
CLH income_statement (annual, 2022-12-31) — Diluted Average Shares: 54487000.00
CLH income_statement (annual, 2022-12-31) — Diluted EPS: 7.56
CLH income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 411744000.00
CLH income_statement (annual, 2022-12-31) — EBIT: 650268000.00
CLH income_statement (annual, 2022-12-31) — EBITDA: 997862000.00
CLH cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -9927000.00
CLH cash_flow (annual, 2022-12-31) — End Cash Position: 492603000.00
CLH cash_flow (annual, 2022-12-31) — Financing Cash Flow: -187315000.00
CLH balance_sheet (annual, 2022-12-31) — Finished Goods: 151519000.00
CLH cash_flow (annual, 2022-12-31) — Free Cash Flow: 279192000.00
CLH cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -8864000.00
CLH income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 8864000.00
CLH balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -167181000.00
CLH balance_sheet (annual, 2022-12-31) — Goodwill: 1246878000.00
CLH balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1867660000.00
CLH balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1009856000.00
CLH balance_sheet (annual, 2022-12-31) — Gross PPE: 4632610000.00
CLH income_statement (annual, 2022-12-31) — Gross Profit: 1622675000.00
CLH cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 78526000.00
CLH income_statement (annual, 2022-12-31) — Interest Expense: 112270000.00
CLH income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 112270000.00
CLH income_statement (annual, 2022-12-31) — Interest Income: 4607000.00
CLH income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4607000.00
CLH cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 105643000.00
CLH balance_sheet (annual, 2022-12-31) — Interest Payable: 20033000.00
CLH balance_sheet (annual, 2022-12-31) — Inventory: 324994000.00
CLH balance_sheet (annual, 2022-12-31) — Invested Capital: 4347150000.00
CLH cash_flow (annual, 2022-12-31) — Investing Cash Flow: -388944000.00
CLH cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CLH balance_sheet (annual, 2022-12-31) — Land And Improvements: 172579000.00
CLH balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 119259000.00
CLH balance_sheet (annual, 2022-12-31) — Long Term Debt: 2414828000.00
CLH balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2534087000.00
CLH cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CLH cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -128473000.00
CLH balance_sheet (annual, 2022-12-31) — Long Term Provisions: 105596000.00
CLH balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1112188000.00
CLH cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -69467000.00
CLH cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -50183000.00
CLH balance_sheet (annual, 2022-12-31) — Net Debt: 1932225000.00
CLH income_statement (annual, 2022-12-31) — Net Income: 411744000.00
CLH income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 411744000.00
CLH income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 411744000.00
CLH income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 411744000.00
CLH income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 411744000.00
CLH cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 411744000.00
CLH income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 411744000.00
CLH cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1966000.00
CLH income_statement (annual, 2022-12-31) — Net Interest Income: -107663000.00
CLH cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 18766000.00
CLH cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -128473000.00
CLH cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -128473000.00
CLH income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -107663000.00
CLH cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -8659000.00
CLH balance_sheet (annual, 2022-12-31) — Net PPE: 2146483000.00
CLH cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -336277000.00
CLH cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CLH balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 54662000.00
CLH balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 350389000.00
CLH balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 350389000.00
CLH income_statement (annual, 2022-12-31) — Normalized EBITDA: 989420000.00
CLH income_statement (annual, 2022-12-31) — Normalized Income: 405285870.00
CLH cash_flow (annual, 2022-12-31) — Operating Cash Flow: 626214000.00
CLH cash_flow (annual, 2022-12-31) — Operating Gains Losses: -8442000.00
CLH income_statement (annual, 2022-12-31) — Operating Income: 634747000.00
CLH income_statement (annual, 2022-12-31) — Operating Revenue: 5166605000.00
CLH balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 54064797.00
CLH balance_sheet (annual, 2022-12-31) — Other Current Assets: 82518000.00
CLH balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 10000000.00
CLH balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 23123000.00
CLH balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -167181000.00
CLH income_statement (annual, 2022-12-31) — Other Income Expense: 10914000.00
CLH balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 620782000.00
CLH balance_sheet (annual, 2022-12-31) — Other Inventories: 29732000.00
CLH cash_flow (annual, 2022-12-31) — Other Non Cash Items: 11098000.00
CLH balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 81803000.00
CLH balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 197219000.00
CLH income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2472000.00
CLH income_statement (annual, 2022-12-31) — Other Operating Expenses: 12943000.00
CLH balance_sheet (annual, 2022-12-31) — Other Properties: 2616118000.00
CLH balance_sheet (annual, 2022-12-31) — Other Receivables: 107010000.00
CLH balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 62033000.00
CLH income_statement (annual, 2022-12-31) — Other Special Charges: 422000.00
CLH balance_sheet (annual, 2022-12-31) — Payables: 508071000.00
CLH balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 720119000.00
CLH balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 123226000.00
CLH income_statement (annual, 2022-12-31) — Pretax Income: 537998000.00
CLH cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CLH balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLH cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 7783000.00
CLH cash_flow (annual, 2022-12-31) — Purchase Of Business: -86278000.00
CLH cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1966000.00
CLH cash_flow (annual, 2022-12-31) — Purchase Of Investment: -49845000.00
CLH cash_flow (annual, 2022-12-31) — Purchase Of PPE: -345056000.00
CLH balance_sheet (annual, 2022-12-31) — Raw Materials: 143743000.00
CLH balance_sheet (annual, 2022-12-31) — Receivables: 1071613000.00
CLH income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3543930000.00
CLH income_statement (annual, 2022-12-31) — Reconciled Depreciation: 347594000.00
CLH cash_flow (annual, 2022-12-31) — Repayment Of Debt: -128473000.00
CLH cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -50183000.00
CLH balance_sheet (annual, 2022-12-31) — Retained Earnings: 1584722000.00